Abstract | Sudden unexpected death in epilepsy (SUDEP) is the leading cause of death in patients with refractory epilepsy, with an estimated 35% lifetime risk in this patient population. There is a surprising lack of awareness among patients and physicians of this increased risk of sudden death: in a recent survey, only 33% of Canadian paediatricians who treated patients with epilepsy knew the term SUDEP. Controversy prevails over whether cardiac arrhythmia or respiratory arrest is more important as the primary cause of death. Effective preventive strategies in high-risk patients will rely on definition of the mechanisms that lead from seizures to death. Here, we summarize evidence for the mechanisms that cause cardiac, respiratory and arousal abnormalities during the ictal and postictal period. We highlight potential cellular mechanisms underlying these abnormalities, such as a defect in the serotonergic system, ictal adenosine release, and changes in autonomic output. We discuss genetic mutations that cause Dravet and long QT syndromes, both of which are linked with increased risk of sudden death. We then highlight possible preventive interventions that are likely to decrease SUDEP incidence, including respiratory monitoring in epilepsy monitoring units and overnight supervision. Finally, we discuss treatments, such as selective serotonin reuptake inhibitors, that might be personalized to a specific genetic or pathological defect.
Introduction
In up to 70% of newly diagnosed patients with epilepsy, seizures can be well-controlled by antiepileptic drugs (AEDs). 1 These patients can remain seizure-free, work, and be active, and if they do have a seizure, the risk of injury is usually minimal as long as they are not driving or at risk of drowning. Despite this generally positive outlook, however, patients with epilepsy still have a 20-fold increased risk of sudden death compared with the general population. 2 Sudden unexpected death in epilepsy (SUDEP) is defined as "the sudden, unexpected, witnessed or unwitnessed, non-traumatic, and non-drowning death of a patient with epilepsy with or without evidence of a seizure, excluding documented status epilepticus, and in which postmortem examination does not reveal a structural or toxicological cause of death. " 3 SUDEP is estimated to cause nearly 2,000 deaths per year in the USA alone 4 -probably an underestimate for reasons that are described below-and accounts for as many as 15% of all epilepsy-related deaths. 5 The most consistent risk factor across multiple studies is an increased frequency of generalized tonic-clonic seizures (GTCS). 6 The epidemiology of SUDEP is beyond the scope of this article, but has been reviewed in detail by Shorvon and Tomson 5 and Hesdorffer and colleagues. 6 No diagnostic test exists for SUDEP, and no autopsy findings have been shown to be pathognomonic for the condition. Therefore, ascertainment of cases is difficult, because coroners or medical examiners might not always identify cases as SUDEP. There is also substantial variability in the patient populations included in epidemiological studies. These factors contribute to the wide variation in estimates of the incidence of SUDEP, ranging from as little as 0.09 per 1,000 person-years among unselected incident cases, up to 9.3 per 1,000 person-years in surgical resection candidates. 5 Among patients with refractory epilepsy, SUDEP has been determined to account for as few as 10% to as many as 50% of all deaths. 5 A recent meta-analysis from the Centers for Disease Control and Prevention has placed the lifetime risk of SUDEP at 35% for this patient group. 4 Although SUDEP accounts for fewer deaths than many other neuro logical dis orders, it occurs at a relatively young age in many patients ( Figure 1 ) and, therefore, accounts for a disproportionate number of 'years of potential life lost' . 4 Despite such a high incidence of SUDEP, a survey indicated that only 56% of Canadian paediatricians who treated children with epilepsy knew that their patients were at an increased risk of sudden death. 7 Furthermore, only 33% of the paediatricians had heard of SUDEP. This lack of awareness has reduced the likelihood of obtaining high-quality respiratory data when a patient dies while being monitored in a hospital. In particular, in most human SUDEP cases, blood pressure, tidal volume and oxygen saturation (SaO 2 ) data are not recorded, and respiratory monitoring is typically not performed.
In this Review, we discuss data, first, from SUDEP cases that were monitored at the time of death; second, from experiments on human peri-ictal cardio respiratory physiology; and third, from recordings of seizure-induced death in animal models. We interpret these data and their relevance to the mechanisms of SUDEP, and consider how they might lead to new treatments and preventive measures that are rationally designed on the basis of known pathophysiology.
Pathophysiology
Seizures are known to induce cardiac arrhythmias, bradycardia and asystole (Figure 2a) , leading many to conclude that SUDEP is attributable to a cardiac mechanism. 8 However, respiratory depression also occurs during and after a seizure, [9] [10] [11] and can be severe enough to cause marked oxygen desaturation (Figure 2b) . 12, 13 These observations prompted a debate about whether the primary, or initiating, event in SUDEP is more frequently an abnormality of breathing, of cardiovascular function, or both. Some reports have hypothesized that pulmonary oedema is a possible cause of death, as mild pulmonary oedema is regularly found on autopsy in SUDEP cases. [14] [15] [16] However, oedema is usually described as mild, and has never been shown to be the primary cause of death. 5 Here we will Key points ■ Overwhelming evidence indicates that sudden unexpected death in epilepsy (SUDEP) is attributable to a seizure causing a primary defect in either cardiovascular or respiratory control or, less commonly, in both ■ From a research perspective, respiratory dysfunction in SUDEP has received less attention than cardiac mechanisms, despite the fact that peri-ictal hypoventilation is common and can lead to severe oxygen desaturation ■ Postictal impairment of wakefulness and arousal probably contributes to the inability of a patient to respond to an external stressor, such as lying prone in bed ■ SUDEP shares many similarities with sudden infant death syndrome, which has been linked to a defect in the 5-hydroxytryptamine (5-HT) system ■ Currently available preventive treatments for SUDEP are designed to decrease seizure frequency; potential approaches that need to be further investigated include targeting of the 5-HT and adenosine systems ■ Routine respiratory monitoring should probably be performed on every patient admitted to an epilepsy monitoring unit focus on the effects of seizures on breathing and cardiac function, and will describe how the depressed level of arousal that occurs after a seizure may play an important part by impairing protective reflexes that would normally prevent death when breathing is impaired or the airway is obstructed. Finally, we will discuss insights obtained about mechanisms from SUDEP cases that were monitored at the time of death.
Seizures and respiratory dysfunction
Lack of oxygenation during seizures was first reported in 1899 when Hughlings Jackson noted his human patients and monkeys "turning blue" during seizures. 9 Since then, others have reported similar findings, and have documented apnoea 10, 17 and oxygen desaturation 11-13 during and after seizures.
Using long-term video-EEG monitoring and respiratory recordings, Nashef and colleagues found that 10 of 17 patients (59%) developed apnoea and six patients experienced a decrease in oxygen saturation to 55-83%, both concurrent with seizures. 12 Investigating 304 seizures in 56 patients with intractable localization-related epilepsy, Bateman and colleagues reported SaO 2 values decreasing below 90% in 33.2% of seizures, and below 70% in 3.6% of seizures. 13 Desaturation was common, and could be severe even with seizures that did not generalize (Figure 2b ). In 100 seizures for which data including airflow measurements were available, central apnoea or hypopnoea occurred in 50% of cases, whereas mixed or obstructive apnoeas occurred in 9% of seizures. In seven patients with 19 seizures for which endtidal carbon dioxide (ETCO 2 ) data were available, SaO 2 below 85% was accompanied by an increase in ETCO 2 of 18.6 ± 17.7 mmHg, indicating hypoventilation. Oxygen desaturation was not unique to GTCS, as SaO 2 decreased below 90% in 34% of partial seizures. These data provide important evidence that respiratory depression can be severe enough to cause SUDEP, but they raise the question of why death is not even more common given the frequency with which seizures induce hypoventilation.
Peri-ictal hypoventilation can lead to cardiac abnormalities. For example, seizures in which SaO 2 decreases to less than 90% can be associated with either prolongation or shortening of the QT interval on the electrocardiogram (ECG). 18 These findings raise a cautionary note, because cardiac changes observed as terminal events in SUDEP cases may be attributable to hypoventilation that would go unnoticed without proper respiratory monitoring. The observations might also explain some of the association between cardiac gene mutations and SUDEP, because hypoventilation due to a primary respiratory event could more easily trigger an arrhythmia in a patient with one of these mutations.
Animal models are a valuable way to determine underlying mechanisms of seizure-induced death. Although DBA/2 mice do not have spontaneous seizures and, therefore, do not meet the criteria for SUDEP, audiogenic seiz ures in these mice lead to respiratory arrest and death. 19 Data from these mice indicate that seizures inhibit the pontomedullary respiratory control network, [20] [21] [22] causing apnoea, followed by asystole and death. Seizure-induced respiratory arrest and death also occur in DBA/1 mice, Htr2c knockout mice, and other epilepsy models. 23, 24 Seizures can have a strong inhibitory effect on breathing, which can be fatal in mouse models. Whether this inhib ition is as strong-and whether it can be fatal-in humans remains unclear.
Seizures and cardiac dysfunction
In 1906, cardiac asystole during a seizure was reported by Russell. 25 Since then, many ictal cardiac abnormalities have been reported, such as a prolonged QT interval, tachycardia, bradycardia, and torsades de pointes (a form of polymorphic ventricular tachycardia). 8, 26 Seizures often induce tachyarrhythmias: 76% of patients with epilepsy experience tachycardia during a seizure, and 57% of all seizures are accompanied by tachycardia. 27, 28 These effects are closely correlated with seizure generalization, and may be due to seizure spread to the hypothalamus with activation of first-order sympathetic neurons. The same studies found that only 2.0% of seizures resulted in bradycardia, and only 0.5% resulted in asystole. Rocamora and colleagues reported that ictal asystole is a rare phenomenon, with only five of 1,244 patients exhibiting asystole concurrent with an ictal event. 29 A retrospective study of 6,825 patients under going longterm video-EEG monitoring reported that ictal asystole occurred in only 0.27% of patients. 30 Moreover, in a study with over 250 seizures in 56 patients, one case of periictal bradycardia was reportedly followed by asystole. 13 This case had concurrent O 2 saturation that fell below 50%, suggesting that brady cardia and asystole might have been secondary to hypoxia due to hypoventilation. Two additional reports have demonstrated that hypercapnia and hypoxia can both lead to tachycardia in individuals with no cardiac abnormalities, 31, 32 consistent with known effects of the respiratory system, and arterial blood gases, on autonomic output.
Repolarization abnormalities such as QT prolongation are common during seizures, and are proposed to contribute to SUDEP pathophysiology. In a study of 76 patients, abnormal ictal prolongation of the QT interval was found in 4.8% of seizures, whereas abnormally shortened QT intervals were observed in 3.8% of seizures. 33 Heart rate variability (HRV) results from modulation of the sinoatrial node by the autonomic nervous system. 34 Patients with temporal lobe epilepsy (TLE) have reduced HRV when compared with the general population, and this reduction is more pronounced during the night. 35, 36 Reports indicate that abnormalities in HRV and cerebro vascular autoregulation could be due to seizure activity, as they improve after epilepsy surgery. 37, 38 HRV defects correlate with surgical outcome-patients with the poorest outcomes have more-marked HRV impairment. 39 Reduced HRV has been associated with increased cardiac mortality and sudden cardiac death, 34, 40 so one might expect HRV to be involved in SUDEP mechanisms. Others have reported an inverse correlation between high-frequency HRV and risk of SUDEP. 41 How ever, a study comparing seven SUDEP cases with seven age-matched controls showed no difference in HRV. 42 Therefore, the role-if any-of HRV in SUDEP pathophysiology remains unclear.
Postictal arousal deficits GTCS 43, 44 and complex partial seizures (CPS) 45, 46 are associ ated with impaired consciousness. Patients with these seizures are unresponsive to commands and questions during the ictus and the postictal state; however, patients with CPS are able to grasp a ball and track a visual stimulus. 47 These data suggest that patients enter a minimally conscious state during CPS. Conversely, following GTCS, patients are in a postictal coma-like state-a much more profound decrease in consciousness that would increase the risk of SUDEP.
Work in the 1930s and 1950s by Penfield and Jasper led to the theory that control of arousal and consciousness involved subcortical structures located in the upper brainstem. 48, 49 These subcortical structures are collectively known as the ascending arousal system (AAS). 50, 51 This system is composed of discrete neurotransmitter-specific nuclei, including the raphe nuclei (5-hydroxytryptamine [5-HT]), 52 the locus coeru leus (norepinephrine), 53 the tuberomammillary nucleus (histamine), the ventral tegmental area (dopamine), 54 the pedunculopontine and laterodorsal tegmental nuclei (acetylcholine), 55 and the parabrachial complex. 56 If a seizure propagates into the brainstem and affects these nuclei, it could alter a patient's level of consciousness. Interestingly, the ascending arousal system has a descending component. The caudal projections increase the neuromodulatory tone of neurons involved in cardiovascular, respiratory and autonomic control, as well as in locomotion and other functions of the hindbrain and spinal cord. 52 Blumenfeld 57 proposed the network inhibition hypothesis to explain how focal seizures can impair consciousness. This theory posits that consciousness is maintained through interactions between the cortex and subcortical structures. Once aberrant discharges start in the cortex, they travel along known anatomical connections to subcortical structures and activate γ-aminobutyric acidreleasing interneurons that inhibit the AAS. With the AAS inhibited, cortical activity is no longer stimulated by neuromodulatory monoamine inputs, resulting in loss of consciousness. Data are available to support this theory: single-photon emission CT has shown increased blood flow starting in temporal lobe structures and descending into the midbrain and brainstem in patients with temporal lobe CPS. 58 Furthermore, recordings from cholinergic neurons in the pedunculopontine tegmental nucleus demonstrate that acetylcholine neurons in the AAS are inhibited during limbic seizures. 59 Loss of consciousness due to AAS inhibition leaves a patient with epilepsy at an elevated risk of SUDEP, as protective reflexes (such as avoiding obstruction of the mouth or coughing in response to aspiration) are not active during the postictal period.
Postictal generalized EEG suppression (PGES) is defined as the profound flattening of the EEG recording after a seizure, and reports have shown that with each second of PGES, the risk of SUDEP increases by 1.7%. 60 PGES has been hypothesized either to cause SUDEP by disrupting cardiorespiratory function in the brainstem or to simply be concurrent with other neural processes that are responsible for death. 60 Although PGES is a common event in patients with GTCS, there is conflicting evidence regarding its relationship to SUDEP. For example, the initial study of 10 cases of SUDEP reported a direct correlation between PGES duration and SUDEP. 60 A later study by a separate group on 19 SUDEP cases and 19 matched controls reported no correlation between the presence or length of PGES and SUDEP. 61 Moreover, Lamberts and colleagues reported that PGES had no apparent effect on heart rate. 62 A critical evaluation indicates that data addressing whether PGES causes SUDEP are lacking; there was simply an association between PGES and SUDEP in one study that remains to be replicated.
An important and real possibility is that PGES could be a biomarker for a defect that contributes to SUDEP. For example, PGES could signify a decrease in monoaminergic tone to the higher cortical areas and decreased arousal, which could occur simultaneously with a decrease in monoaminergic tone to the brainstem cardiorespiratory centres. Alternatively, PGES may represent depression of neuronal activity due to loss of blood flow to the brain, which, when the brain is postictal, could manifest differently from the progressive development of slowing normally seen with hypoxia-ischemia. 63 MORTEMUS: respiratory versus cardiac Our current understanding of SUDEP comes from a variety of sources. The cardiorespiratory response to seizures has been measured in patients admitted to epilepsy monitoring units (EMUs), but whether the observed effects in patients who survive are relevant to the fatal events of SUDEP remains unclear. Data are available from seizure-induced death in animal models, but we do not know whether these mechanisms are the same as those in human SUDEP. Human SUDEP cases provide the most relevant source of data, including information from death scene investigations, deaths witnessed by nonmedical personnel, and deaths of patients while being monitored in the hospital.
Fortunately, it is rare for patients to die while being monitored for seizures in EMUs. However, the common practice of withdrawing anticonvulsant medications to increase the likelihood of capturing a seizure may increase the risk of SUDEP. In the MORTality in Epilepsy Monitoring Units Study (MORTEMUS), out of 93,791 monitored patients and 1,771 patient-years of recording, 16 cases of definite or probable SUDEP (combined here as 'SUDEP') and nine cases of 'near SUDEP' were reported. 16 The data from each of these cases were carefully scrutinized to document the events leading up to death. This analysis clearly documented several important findings that had previously been suggested, but had not been convincingly demonstrated. First, 16 of 16 SUDEP and 7 of 9 near-SUDEP events occurred after GTCS; second, 14 of 16 SUDEP events occurred at night; third, 14 of 16 patients died in a prone position; and last, cardiopulmonary resuscitation (CPR) was successful in 7 of 7 cases when started within 3 min, but was not successful in 8 of 8 cases when started after 10 min.
According to the MORTEMUS findings, a consistent sequence of events occurred after each seizure that resulted in SUDEP. 16 Rapid breathing at 18-50 breaths per min began immediately after the seizure, followed by apnoea, bradycardia and PGES. One-third of the cases did not recover. The others exhibited transient return of breathing movements and the QRS complex on the ECG, but the authors suggested the possibility of "ineffective respiration probably aggravated by the prone position. " 16 Some patients were noted to be lying face down and died without apparent struggle, as if they were unaware of being in danger. In some cases, "gasping" occurred transiently. Terminal apnoea always occurred first, followed by terminal asystole. The authors concluded that SUDEP began with "an early, centrally mediated, severe alteration of both respiratory and cardiac functions after generalized tonic-clonic seizures. "
MORTEMUS is a landmark study, but this retrospective review of SUDEP cases has some limitations. No direct measurements of breathing, such as ventilation, tidal volume, airflow, blood gases or O 2 saturation, were made in any of the patients. Breathing was evaluated by visual observation of the video, the only quantified variable being respiratory rate. Therefore, it was not possible to rule out paradoxical breathing, airway obstruction or other ineffec tive respiratory effort despite normal or increased respiratory rate. Furthermore, since GTCS was the precipitating event in every case, it is possible that convulsions prevented accurate counting of inspirations. As the authors point out, "respiration is withheld during GTCS, resulting in ictal hypoxaemia in 33% of cases. 13 Thus, brain oxygenation might well be already compromised before postictal apnoea in GTCS-induced SUDEP. " 16 In summary, during a seizure, the patient might exhibit severe hypoventilation, leading to oxygen debt, and respiratory acidosis. Immediately after termination of the seizure, cardiac and respiratory function may be transiently restored, but possibly not sufficiently to reverse the profound alteration in blood gases that occurred during the ictus. A respiratory rate of 50 breaths per min is very unusual and probably signifies a severe increase in respiratory drive. Ineffective respiration could be aggravated by the prone position, owing to the greater strength needed to increase thoracic volume. As noted, there may also be no attempt to overcome these problems, since the patient is in a 'postictal state' of decreased arousal, and might be unaware of the dangerous circumstances. No autopsy was performed in 50% of the MORTEMUS cases but, given the amount of information available on each patient up to and at the time of death, including a video recording of the death, an autopsy is unlikely to have changed the diagnosis for many of the patients with probable SUDEP, if any at all. 16 The MORTEMUS data are unique in their scope and, despite some limitations, are unprecedented in defining common events preceding SUDEP. The results of this study and others clearly indicate that individual SUDEP cases involve effects on both the respiratory and cardiovascular systems. 16, [64] [65] [66] [67] [68] [69] For any specific SUDEP case, it has been difficult to draw a firm conclusion about whether respiratory or cardiac dysfunction was first to appear. The observation that "terminal apnoea always preceded terminal asystole" is irrelevant to this question, because the terminal events occur long after the initiating events. In some instances, apnoea and arrhythmia may both occur at the onset-a phenomenon referred to as 'neurovegetative breakdown' . 16 In other cases, failure of respiratory rhythm generation (central apnoea) might be the primary cause of death, whereas in others the initiating factor could be cardiac or autonomic dysfunction. In the absence of firm data, we cannot rule out the possibility that one of these three possibilities is much more common than the others.
Genetics
Several genes have been associated with documented cases of SUDEP (Table 1) . Genetic screening of families of patients who succumbed to SUDEP might uncover genes that are important for maintenance of cardiorespiratory function during seizures or in response to hypoxia. 70 Mutations have been identified that confer an increased risk of sudden death, such as in long QT syndrome (LQTS) and Dravet syndrome.
Long QT syndrome LQTS has been attributed to mutations in 13 or more genes that are all expressed in the heart. These mutations lead to a prolonged cardiac action potential, syncope, ventricular tachycardia, and sudden death. 71 The syndrome is a major cause of malignant ventricular arrhythmias and sudden death in younger individuals with otherwise normal hearts. Almost 50% of LQTS cases are caused by a mutation in the KCNQ1 gene, which encodes the α subunit of the voltage-gated potassium channel K v 7.1.
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This mutation disrupts the slow repolarizing I Ks current, leading to increased cardiac action potential duration. 72 LQTS-associated genes are expressed throughout the body, and at least 12 are expressed in the brain. The majority of mutations that cause LQTS are in genes encoding ion channels that are critical for normal cardiomyocyte function, and it has become clear that some of the genes are also important for neuronal function.
A seizure phenotype-defined as the presence of either a personal or family history of seizures or epilepsy, or a history of antiepileptic therapy-has been reported to be present in about 29% of patients with LQTS. 72 Seizure phenotypes were more common in LQT2 than in LQT1 and LQT3 (caused by mutations in KCNH2, KCNQ1 and SCN5A, respectively)-these three subtypes together constitute about 75% of all LQTS patients. 73 Although cardiac syncope often presents with features mimicking a seizure (convulsive syncope), a recent study reported that 15% of LQTS patients with reported seizures have epileptiform activity on EEG, indicating that they are likely to have epilepsy. 74 However, these data may underestimate the percentage of LQTS patients who have epilepsy, as it has been reported that only 38% of patients with epilepsy have epileptiform activity on a single routine EEG. 75 Two mouse strains that carry mutations in Kcnq1 recapit ulate the human cardiac phenotype and die unexpec tedly. 76 These mice also have epileptiform activity on their EEGs, with frequent partial and generalized seizures. 77 Simultaneous EEG and ECG recordings demonstrate that interictal hypersynchronous cortical discharges coincide with either prolongation of the cardiac RR interval and premature ventricular contractions, or asystole, 77 which are commonly associated with autonomic instability and have been reported in SUDEP cases. 78 KCNA1, which encodes the K v 1.1 potassium channel, is also expressed in the brain and heart. Deletion of this gene in mice leads to severe seizures with a high rate of sudden death. 79 K v 1.1 deficiency alters parasympathetic neurotransmission and disrupts cardiac rhythmicity. 79 Research to date has focused on the effects of LQTS mutations on cardiac function, but it will also be important to determine the role of these genes in brain function, whether they are expressed in autonomic, cardiac or respiratory neurons, and whether mutations lead to changes in control of the heart and/or breathing, or increased apnoea after seizures.
Dravet syndrome
Dravet syndrome is a severe childhood-onset form of epilepsy, which typically manifests as febrile seizures in the first year of life and develops into refractory polymorphic seizures. 80 Affected children have comorbidities, including psychomotor regression, ataxia, sleep disturbance, cognitive impairment, and sudden death. Some of these comorbidities are caused by seizures. 81, 82 The genetic cause of Dravet syndrome in 80% of cases is a loss-of-function mutation in SCN1A, which encodes the pore-forming subunit of the Na v 1.1 voltage-gated sodium channel. 83, 84 SCN1A is expressed in both the brain and the heart, and has a crucial role in the normal function of both organs. 85, 86 Intrinsic cardiac abnormalities in Dravet syndrome are well-documented. 80 A mouse model of Dravet syndrome recapitulates many aspects of the clinical condition, and offers a research tool for understanding the mechanisms underlying SUDEP. 87 Studies in these mice have reported suppressed interictal resting heart rate variability and instances of ictal brady cardia that correlated with tonic phases of GTCS. 88 Death after prolonged ictal-onset bradycardia has also been reported in these animals. 88 Muscarinic antagonists decrease bradycardia and seizure-induced death in a mouse model of Dravet syndrome, suggesting that SUDEP is initiated by increased vagal parasympathetic output, causing lethal bradycardia. 80 These mouse data parallel findings from patients with Dravet syndrome, who have suppressed resting HRV compared with the general population or patients with epilepsies other than Dravet syndrome. 89 These studies have yielded convin cing evidence that cardiac mechanisms could contribute to death in some cases. However, experiments have not been conducted to determine whether respiratory dysfunction might contribute to SUDEP in humans or in mice with Dravet syndrome mutations.
Cellular mechanisms
The majority of research on mechanisms of SUDEP has focused on cardiac electrophysiology and seizure activity in the cortex. Clues from recent animal experiments and 135 Napolitano et al.
136 *Loss-of-function mutation. ‡ Gain-of-function mutation. Abbreviations: NA, not applicable; SUDEP, sudden unexpected death in epilepsy.
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work on brain slices, however, point to possible brainstem mechanisms involving 5-HT and adenosine, as well as autonomic dysfunction.
5-hydroxytryptamine
5-HT is a monoamine neurotransmitter found in the raphe and related nuclei that has a variety of functions in the brain, including stimulation of breathing. 90, 91 Mice lacking the 5-HT 2C receptor exhibit recurrent seizures and sudden death following a seizure. 23 Furthermore, postictal respiratory arrest in DBA/2 mice can be prevented with the selective serotonin reuptake inhibitor (SSRI) fluox etine, 92 and these mice have aberrant 5-HT receptor expression in some regions of the brainstem. 93 In patients with medically refractory partial epilepsy, SSRIs are reported to decrease the likelihood of ictal hypox aemia. 94 These data have been interpreted to indicate that a defect in the 5-HT system might increase susceptibility to SUDEP. However, the protective effect of fluoxetine in DBA/2 mice does not necessarily mean that SUDEP is caused by a decrease in 5-HT levels, even in mice.
A role for 5-HT dysfunction in SUDEP is consistent with the known critical role of 5-HT in control of breathing. 21, 90, [95] [96] [97] [98] Normal respiratory control is dependent on neurons in the medulla and pons that generate and shape the respiratory motor output. 22 Respiratory neurons are concentrated in the nucleus of the solitary tract (NTS), nucleus ambiguus, pre-Bötzinger complex (preBötC), retrotrapezoid nucleus, Kölliker-Fuse nucleus, and other regions of the lower brainstem (Figure 3) . 22 5-HT neurons project to and stimulate neurons in each of these nuclei. 21 ,90,99 5-HT and thyrotropin-releasing hormone, both released from raphe neurons, induce pacemaker activity in neurons of the preBötC 90 and the NTS, 100 respectively, thereby enhancing respiratory motor output. Lmx1b f/f/p mice, in which essentially all 5-HT neurons are genetically deleted during in utero development, exhibit apnoea and high mortality during the neonatal period, 97 have blunted CO 2 chemoreception as adults, 95 and show a defect in arousal from sleep in response to increased CO 2 .
101 DOI, a 5-HT 2A/1C receptor agonist, decreases the apnoeic episodes seen in neonatal Lmx1b f/f/p mice, 97 and exogenous 5-HT can rescue the decreased hypercapnic ventilatory response (HCVR) in adult Lmx1b f/f/p mice. 95 These observations indicate that a defect in the 5-HT system could increase the likelihood of SUDEP. After a seizure, abnormal function of the 5-HT system could lead to an arousal defect and a blunted HCVR. Together, these effects would cause respiratory acidosis and hypoxaemia, with death occurring due to failure of the patient to arouse and increase ventilation.
A defect in the 5-HT system could also explain comorbid ities, such as depression, that are observed in a considerable proportion of patients with refractory epilepsy. 102 Patients with epilepsy show a correlation between high Neurological Disorders Depression Inventory for Epilepsy scores, which denote major depression, and frequency of seizures. 103 Increased seizure frequency is often cited as a risk factor for SUDEP, so a defect in the 5-HT system could put patients at greater risk of SUDEP. Further experiments are needed to determine whether mouse models and human cases of SUDEP show defects in the 5-HT system similar to those observed in experiments on brainstem tissue from cases of sudden infant death syndrome (SIDS; Box 1), 104 and whether interventions to stimulate the 5-HT system in humans could help reduce apnoea and prevent SUDEP.
Adenosine
Adenosine is an inhibitory modulator of neuronal activity. Adenosine receptors are expressed throughout the nervous system, and activation of A 1 receptors has anticonvul sant effects. 105 During seizures, adenosine levels increase in the brain and suppress seizure activity. 106 However, activation of adenosine receptors in the brainstem also induces severe respiratory depression. 107 If seizures caused an increase in extracellular adenosine in the brainstem, this would lead to hypoventilation, apnoea, and arrhythmias in the postictal period.
In a study by Shen and colleagues, mice were treated with pharmacological inhibitors of adenosine deaminase and adenosine kinase-enzymes that are responsible for metabo lizing adenosine 105 -and were then given kainic acid to induce seizures. 108 The mice were protected from seizures for the first 15 min but, following this initial period, they all developed severe seizures and died. If the mice were treated with caffeine (an adenosine receptor antagonist) at seizure onset, however, their survival time was significantly increased compared with their untreated counterparts. On the basis of these findings, Shen and colleagues concluded that adenosine is responsible for seizure-induced death.
Caution should be exercised when attempting to extend these results to SUDEP, for two reasons. First, the mice were given a large dose of kainic acid that induced death due to status epilepticus, which excludes a SUDEP diagnosis. Second, the mice died even after caffeine treatment, indicating that caffeine is not an effective treatment for preventing death in this model. More research is required on the effects of caffeine on cardiorespiratory function in the peri-ictal period in mouse models with induced and spontaneous seizures that lead to death in the absence of status epilepticus. Despite these caveats, increased adenosine levels remain a possible mechanism for postictal cardiorespiratory depression in patients with epilepsy. Caffeine is already used to treat premature infants with apnoea, 109 and could, therefore, be a viable treatment for seizure-associated hypoventilation.
Sympathetic denervation
Data supporting alterations in sympathetic and parasympathetic tone in patients with epilepsy have been inconsistently reported. 37, [110] [111] [112] [113] Studies have used 123 I-metaiodobenzylguanidine (MIBG) to quantify cardiac sympathetic regulation in patients with epilepsy. [114] [115] [116] MIBG uptake into myocardial sympathetic nerve terminals is reduced in patients with chronic TLE, indicative of decreased postganglionic sympathetic innervation. 114 Patients with TLE who had ictal asystole showed decreased MIBG uptake compared with those who did not have asystole. 115 In patients who underwent surgical temporal lobe resection, cardiac sympathetic denervation, as assessed by MIBG uptake, continued to progress; however, the denervation was greater in patients who continued to experience seizures. 116 Data from these MIBG studies indicate that seizures in patients with epilepsy might induce sympathetic denervation and autonomic dysfunction. According to one hypothesis, the decreased innervation seen in these studies could induce hypersensitivity of β-adrenergic receptors in the heart. 8 Denervation-induced hypersensitivity might explain the increased effect of sympathetic input on heart rate, leading to tachycardia during seizures. 117 Augmented sympathetic activity can lead to secondary cardiac problems such as transient dilatation of ventricular walls, causing Takotsubo cardio myopathy. 118 This pathology has been reported in GTCS, and could cause cardiac dysfunction in patients with epilepsy. 119 
From mechanisms to prevention
Given that frequency of GTCS is the most consistently reported risk factor for SUDEP, 5 the only current preventive measure to decrease SUDEP risk is control of seizures by antiepileptic drugs (AEDs) or surgical resection. However, these treatment strategies alone would not decrease the number of SUDEP cases as much as would be desirable. On the basis of our current knowledge of SUDEP epidemiology and pathophysiology, there are several measures that can be taken immediately to reduce the incidence of SUDEP, as well as some treatments that need to be further investigated.
Multiple reports have documented SUDEP cases occurring in hospital EMUs while patients were being monitored, 16, [64] [65] [66] 69 but none of these reports included respiratory monitoring of the patients other than video inspection. Hospital EMUs should, at a minimum, institute monitoring of SaO 2 , which would alert health-care providers to hypoventilation. Supervision during nighttime hours has been reported to be protective against SUDEP. 120, 121 Systems of supervision, such as continuous nocturnal sound monitoring systems, regular checks by an individual throughout the night, and the presence of a person in the same room at night, should be systematically evaluated. These meas ures, combined with home monitoring and CPR training, have the potential to decrease SUDEP.
Other more-speculative treatments that might alleviate SUDEP risk are based on knowledge of the Box 1 | Parallels with sudden infant death syndrome Sudden unexpected death in epilepsy (SUDEP) and sudden infant death syndrome (SIDS) share many similarities, 102, 137 and both are linked to defects in the 5-hydroxytryptamine (5-HT) system. SIDS is defined as death of an infant in the first year of life, which is often associated with sleep, and the cause of death is not identified on autopsy, death scene investigation, or complete review of the clinical history. 138 This definition is very similar to that of SUDEP. Both are diagnoses of exclusion, and there are no pathognomonic findings on autopsy. Like SUDEP, SIDS is thought to be caused by cardiorespiratory dysfunction and arousal deficits, and current research includes a large amount of work focused on the role of 5-HT in arousal and breathing. 104, 139 Multiple defects in the medullary 5-HT system have been reported in SIDS cases, including increased numbers of 5-HT neurons of immature appearance; 140 reduced 5-HT 1A ligand binding in the raphe nuclei; 140 and reduced 5-HT levels. 141, 142 The many similarities between the two syndromes reinforce the evidence that 5-HT dysfunction has a role in SUDEP. Indeed, the possibility has been raised that some SIDS cases are actually SUDEP. A patient with epilepsy has a seizure that spreads to the brainstem. Spread to the upper brainstem causes acute dysfunction of the ascending arousal system, including 5-HT neurons, which leads to PGES and arousal failure. When combined with the face in pillows or bedding, the arousal failure leads to hypoventilation. Seizure spread into the medulla causes disruption of the descending arousal system, which, along with increased extracellular adenosine levels, precipitates dysfunction in both respiratory nuclei and autonomic and cardiovascular control. Hypoventilation and arrhythmias develop and lead to severe hypercapnia, hypoxia and death. Abbreviations: 5-HT, 5-hydroxytryptamine; PGES, postictal generalized EEG suppression; SUDEP, sudden unexpected death in epilepsy.
pathophysiology, and should be considered for clinical testing. Implantation of cardiac pacemakers or defibrillators has been proposed as an effective treatment to prevent arrhythmias in patients at high risk of SUDEP.
122
Vagus nerve stimulation (VNS) is used in some patients with epilepsy who do not respond to AEDs, and is effective at decreasing seizure frequency. 123 This finding alone might explain why one small trial reporting a modest reduction in SUDEP risk prompted the American Academy of Neurology to publish a position statement advocating the use of VNS for prevention of SUDEP. 124 However, the question of whether VNS is more effective than any other method of seizure control, such as AEDs, for preventing SUDEP remains to be addressed, and it seems premature to use VNS specifically to prevent SUDEP; instead, the treatment that is best for prevention of seizures should be chosen. If respiratory arrest is the cause of death in a subset of SUDEP cases, a VNS device could include a separate wire to the phrenic nerve(s). Respiratory output could be monitored with either the phrenic nerve electrode or the vagus nerve electrode. If the patient stops breathing after a seizure, the diaphragm could be paced on demand until recovery.
Patients with refractory seizures might benefit from SSRIs to prevent postictal hypoventilation and hypoxaemia. 94 The anticonvulsant properties of 5-HT could also reduce the frequency of seizures. 125 Other ways to enhance 5-HT signalling may be discovered that are more specific for breathing and arousal, such as agonists for 5-HT receptors on respiratory neurons. Treatments that target adenosine, such as caffeine, might be effective for patients who have adenosine-induced cardiorespiratory dysfunction, or as a nonspecific respiratory stimulant. Each of these treatments needs to be studied in clinical trials before they can be deployed to decrease SUDEP risk, but preclinical studies have provided a strong rationale for clinical testing in several cases. At some point in the near future, biomarkers might be discovered that identify specific mechanisms for SUDEP risk in each individual patient, leading to personalized treatment targeted to a specific genetic defect, receptor mechanism or failed organ.
Conclusions and hypothesis
The mechanisms of SUDEP remain poorly defined. Cardiac and respiratory abnormalities both occur during and after seizures, and typically along with loss of consciousness. On the basis of current evidence, we propose a hypothesis in which seizures activate neurons that project to the midbrain and medulla and inhibit monoaminergic and cholinergic neurons of the AAS, including the component that descends to the cardiac and respiratory networks in the medulla (Figure 4) . Activity of cardiovascular and respiratory neurons would be inhibited in conjunction with suppression of cortical activity. At the end of the seizure, inhib ition of the AAS would cause PGES. Hypoventilation during the seizure would be followed by severe post ictal hyper capnia and hypoxia. These blood gas derangements could then lead to bradycardia, asystole, and death ( Figure 4) . Using a theoretical case, Figure 5 shows physio logical variables during an episode of SUDEP, illustrating the sequence of events that might occur during a primary respiratory event.
Given the heterogeneity of SUDEP, this hypothesis is one of a number of possibilities, which include cardiac causes. Mouse models of SUDEP may be valuable to test the hypothesis, to investigate cellular mechanisms, and to define the roles of 5-HT and adenosine. Ultimately, adoption of preventive strat egies will rely on identification of biomarkers for individuals at high risk of SUDEP, and for determining which of the possible underlying mechanisms is operating in each patient. On seizure generalization, apnoea occurs, causing acceleration of the blood gas changes, and tachycardia. In the postictal state, PGES occurs due to loss of drive from the ascending arousal system, but there is transient tachypnoea due to powerful drive from decreased PO 2 and increased PCO 2 . However, ventilation is inadequate due to either airway obstruction or decreased effort. PO 2 drops to dangerously low levels causing terminal gasps, but autoresuscitation fails. The patient's heart slows due to parasympathetic drive and blood gas derangements, and then stops. Abbreviations: ECG, electrocardiogram; PCO 2 , partial pressure of carbon dioxide; PGES, postictal generalized EEG suppression; PO 2 , partial pressure of oxygen; TV, tidal volume.
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